At present, Perspective Therapeutics Inc (CATX) has a stock price of $0.25. In the previous session, the stock saw a rise, peaking at $0.26 after an opening price of $0.26. The day’s lowest price was $0.24, and it closed at $0.23.
In terms of market performance, Perspective Therapeutics Inc had a fairly uneven. The highest value for the stock in the past year was $0.73 on 06/22/23, and the lowest value was recorded at $0.20 on 09/15/23.
52-week price history of CATX Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Perspective Therapeutics Inc’s current trading price is -65.50% away from its 52-week high, while its distance from the 52-week low is 22.83%. The stock’s price range during the 52-week period has remained between $0.20 and $0.73. In the Healthcare sector, the company’s shares saw a trading volume of around 0.63 million for the day, which was evidently lower than the average daily volume of 0.99 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Perspective Therapeutics Inc (CATX) has experienced a quarterly decline of -34.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 70.65M.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4095, with a change in price of -0.4132. Similarly, Perspective Therapeutics Inc recorded 731,181 in trading volume during the last 100 days, posting a change of -62.14%.
Examining CATX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CATX stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
CATX Stock Stochastic Average
As of today, Perspective Therapeutics Inc’s raw stochastic average for the last 50 days stands at 15.68%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 35.26%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 19.39% and 14.94%, respectively.
CATX Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 1.90%.However, over the last six months, we can see a stronger performance of -44.50%. Over the last 30 days, the price of CATX has leaped by -12.57%. And in the last five days, it has fallen by -8.07%.